Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies

    ... less than 20% bone marrow or peripheral blood blasts . Acute myeloid leukemia in first remission with any of the ...

    Clinical Trial last updated 06/06/2016 - 1:18pm.

  2. Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    ... remission, with remission defined as <5% bone marrow blasts morphologically. g. Poor-risk acute leukemia in first remission, with remission defined as <5% bone marrow blasts morphologically: i. AML with at least one of the following: AML arising ...

    Clinical Trial last updated 05/02/2016 - 2:38pm.

  3. RIC Transplant Using Haplo Donors

    ... complete remission; first complete remission; marrow blasts <5%, but persistence of minimal residual disease by flow ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  4. How long do I have to live?

    ... you have Percentage of young white blood cells ( blasts ) in bone marrow cells Number of cytogenetic changes (abnormal ...

    FAQ last updated 03/15/2016 - 11:34pm.

  5. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... 4) refractory anemia with excess of blasts , 5) transformation to acute leukemia, 6) chronic myelomonocytic ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  6. Lower-Risk MDS: Diagnosis and Treatment Options

    ... 100,000/mm3. The second criterion is the percentage of blasts , or immature white blood cells in the bone marrow , ... is the World Health Organization (WHO) classification, 20% blasts or greater establishes a diagnosis of acute myeloid leukemia, rather ...

    Interview last updated 05/18/2012 - 1:28pm.

  7. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... T lymphoblastic lymphoma); remission is defined as < 5% blasts with no morphological characteristics of acute leukemia (e.g., Auer ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.

  8. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... to therapy, or high risk cytogenetics . Blasts must be less than 5%. If >5% requires therapy (induction or ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  9. Recent developments in myelodysplastic syndromes

    ... chromosomal abnormalities, bone marrow blasts , cytopenias, age, and additional factors to determine prognosis.  ...

    Research Review last updated 05/02/2016 - 9:16am.

  10. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... high risk and CMML with bone marrow blasts <5%); or Secondary acute myeloid leukemia on the basis of ...

    Clinical Trial last updated 05/02/2016 - 11:10am.